Proprietary AI analyst is now available

Shanghai C&D Innostic Valuation Multiples

Discover revenue and EBITDA valuation multiples for Shanghai C&D Innostic and similar public comparables like CropEnergies, Ecovyst, Chemtrade Logistics, Alpek and more.

Shanghai C&D Innostic Overview

About Shanghai C&D Innostic

Shanghai C and D Innostic Medical Technology Group Co Ltd is engaged in Direct sales and distribution of medical devices, and provision of services such as intensive operation of medical consumables (SPD) to terminal hospitals.


Founded

2010

HQ

China

Employees

N/A

Sectors

Financials (FY)

Revenue: $3B
EBITDA: $100M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Shanghai C&D Innostic Financials

Shanghai C&D Innostic reported last fiscal year revenue of $3B and EBITDA of $100M.

In the same fiscal year, Shanghai C&D Innostic generated $228M in gross profit, $100M in EBITDA, and $40M in net income.

Revenue (LTM)


Shanghai C&D Innostic P&L

In the most recent fiscal year, Shanghai C&D Innostic reported revenue of $3B and EBITDA of $100M.

Shanghai C&D Innostic is profitable as of last fiscal year, with gross margin of 8%, EBITDA margin of 3%, and net margin of 1%.

See analyst estimates for Shanghai C&D Innostic
Last FY202320242025202620272028
Revenue$3B$2B$3B$3B
Gross Profit$228M$179M$200M$228M
Gross Margin8%8%8%8%
EBITDA$100M$103M$130M$100M
EBITDA Margin3%5%5%3%
EBIT Margin4%3%3%4%
Net Profit$40M$29M$34M$40M
Net Margin1%1%1%1%
Net Debt$237M---

Financial data powered by Morningstar, Inc.

Shanghai C&D Innostic Stock Performance

Shanghai C&D Innostic has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


Shanghai C&D Innostic's stock price is $3.32.

Shanghai C&D Innostic share price decreased by 2.2% in the last 30 days.

Shanghai C&D Innostic has an EPS (earnings per share) of $0.09.

See more trading valuation data for Shanghai C&D Innostic
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B-2.4%-2.2%-16.6%-$0.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Shanghai C&D Innostic Valuation Multiples

Shanghai C&D Innostic trades at 0.6x EV/Revenue multiple, and 16.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Shanghai C&D Innostic

EV / Revenue (LTM)


Shanghai C&D Innostic Financial Valuation Multiples

As of June 5, 2026, Shanghai C&D Innostic has market cap of $1B and EV of $2B.

Shanghai C&D Innostic has a P/E ratio of 35.1x.

Last FY202320242025202620272028
EV/Revenue0.6x0.7x0.6x0.6x
EV/EBITDA16.9x16.3x13.0x16.9x
EV/EBIT16.4x23.2x19.2x16.4x
EV/Gross Profit7.4x9.4x8.4x7.4x
P/E35.1x48.2x41.4x35.1x
EV/FCF17.1x(24.9x)n/m17.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Shanghai C&D Innostic Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Shanghai C&D Innostic Margins & Growth Rates

In the most recent fiscal year, Shanghai C&D Innostic reported gross margin of 8%, EBITDA margin of 3%, and net margin of 1%.

See estimated margins and future growth rates for Shanghai C&D Innostic

Shanghai C&D Innostic Margins

Last FY20242025202720282029
Gross Margin8%8%8%
EBITDA Margin3%5%3%
EBIT Margin4%3%4%
Net Margin1%1%1%
FCF Margin3%0%3%

Shanghai C&D Innostic Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth16%8%
Gross Profit Growth11%14%
EBITDA Growth26%(23%)
EBIT Growth21%17%
Net Profit Growth16%18%
FCF Growth(110%)1437%

Data powered by FactSet, Inc. and Morningstar, Inc.

Shanghai C&D Innostic Operational KPIs

Access forward-looking KPIs for Shanghai C&D Innostic
Last FY202320242025202620272028
S&M Expenses to Revenue1%3%2%1%
G&A Expenses to Revenue0%1%1%0%
R&D Expenses to Revenue0%0%0%0%
Opex to Revenue4%5%4%4%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Shanghai C&D Innostic Competitors

Shanghai C&D Innostic competitors include CropEnergies, Ecovyst, Chemtrade Logistics, Alpek, CAC Nantong Chemical Co, Elkem, Braskem, Unipar, CVR Partners and Redox.

Most Shanghai C&D Innostic public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
CropEnergies244.6x-(10.0x)-
Ecovyst2.3x2.0x9.8x9.2x
Chemtrade Logistics1.6x-6.9x-
Alpek0.4x0.5x6.7x6.0x
CAC Nantong Chemical Co2.0x1.9x10.3x-
Elkem0.7x0.9x5.6x8.3x
Braskem1.0x1.0x9.7x11.5x
Unipar1.7x1.7x6.6x7.7x

This data is available for Pro users. Sign up to see all Shanghai C&D Innostic competitors and their valuation data.

Start Free Trial

Shanghai C&D Innostic VC Funding History

Before going public, Shanghai C&D Innostic raised $39M in total equity funding, across 1 round.


Shanghai C&D Innostic Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jan-18Series AJune Lead Capital; ORIX; Qiaojing Capital; Qiming Venture Partners; Shanghai Blossom Investment Management$39M-Shanghai C&D Innostic, also referred to as Shanghai Innostic Supply Chain Management Co., Ltd or Innostic, operates as a medical consumables management platform and supply chain company in China, focusing on high-growth areas like medical consumables and diagnostics. In January 2018, it raised CNY 250 million (approximately US$39 million) in a Series A funding round led by ORIX Corporation, with participation from Qiming Venture Partners and others matching the query's investor list including June Lead Capital, Qiaojing Capital, and Shanghai Blossom Investment Management. This round supported its positioning in China's booming med-tech sector amid policy support, demographic shifts, and AI-driven innovation. The company has since progressed toward public markets, planning a Shenzhen Stock Exchange IPO offering up to 63,193,277 shares underwritten by CITIC Securities, targeting capital raise in the context of a medical technology market projected at US$48.45 billion by 2025 with a 7.34% CAGR to US$69.05 billion by 2030.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Shanghai C&D Innostic

When was Shanghai C&D Innostic founded?Shanghai C&D Innostic was founded in 2010.
Where is Shanghai C&D Innostic headquartered?Shanghai C&D Innostic is headquartered in China.
Is Shanghai C&D Innostic publicly listed?Yes, Shanghai C&D Innostic is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Shanghai C&D Innostic?Shanghai C&D Innostic trades under 301584 ticker.
When did Shanghai C&D Innostic go public?Shanghai C&D Innostic went public in 2025.
Who are competitors of Shanghai C&D Innostic?Shanghai C&D Innostic main competitors include CropEnergies, Ecovyst, Chemtrade Logistics, Alpek, CAC Nantong Chemical Co, Elkem, Braskem, Unipar, CVR Partners, Redox.
What is the current market cap of Shanghai C&D Innostic?Shanghai C&D Innostic's current market cap is $1B.
What is the current revenue of Shanghai C&D Innostic?Shanghai C&D Innostic's last fiscal year revenue is $3B.
What is the current EV/Revenue multiple of Shanghai C&D Innostic?Current revenue multiple of Shanghai C&D Innostic is 0.6x.
Is Shanghai C&D Innostic profitable?No, Shanghai C&D Innostic is not profitable.
How many companies Shanghai C&D Innostic has acquired to date?Shanghai C&D Innostic hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Shanghai C&D Innostic has invested to date?Shanghai C&D Innostic hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Shanghai C&D Innostic

Lists including Shanghai C&D Innostic

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial